https://www.biopharmadive.com/news/verdiva-obesity-biotech-startup-launch-sciwind-china/736880/
Verdiva starts up with $411M and a portfolio of obesity drugs from China | BioPharma Dive
The newly launched biotech is equipped with rights to a trio of weight loss medicines licensed from China-based Sciwind Biosciences, led by an oral therapy...